Stéphane Bancel has always liked to burn the steps. But, these last few months, this forty-something woman in marseille has put the turbo. Moderna, a biotech company that he has directed for seven years on the east coast of the u.s., was launched in mid-march the first clinical trial in the United States of an experimental vaccine against the Covid-19 on humans. The forty-something woman has just announced the launch at the end of July, phase 3 of the experiment that will test the about 30 000 people, the effectiveness of the treatment, positioning itself as one of the companies most advanced in the fight against the pandemic. The deve…
Article reserved to subscribers
Already a subscriber ?
sign in
Not a subscriber yet ?
Subscribe
